Evidence map›Paper›PMID 23811610›Full record

Observational studyHuman vaccines & immunotherapeutics2013

Field seasonal influenza vaccine effectiveness: evaluation of the screening method using different sources of data during the 2010/2011 French influenza season.

Alessandra Falchi, Cecile Souty, Marie-Lise Grisoni, Anne Mosnier, Thomas Hanslik, Isabelle Daviaud, Laurent Varesi, Solen Kerneis, Fabrice Carrat, Thierry Blanchon

Open access · bronzeAbstract readObservational Study
In one paragraph

Observational study in Human vaccines & immunotherapeutics, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. New theoretical ISM-K2 Bayesian network model for evaluating vaccination effectiveness.Journal of ambient intelligence and humanized computing · 2022
    Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 7 institutions in 3 countries.

Alessandra FalchiINSERM; U707; Paris, France; Laboratoire de Virologie; EA 7310 Université de Corse; Corte, France; UPMC Univ Paris 06; UMR S 707; Paris, France.
Cecile Souty
Marie-Lise Grisoni
Anne Mosnier
Thomas Hanslik
Isabelle Daviaud
Laurent Varesi
Solen Kerneis
Fabrice Carrat
Thierry Blanchon
Eau de Paris (France) · FRInserm · FRUPMC Health System · US3M (United States) · USHôpital Ambroise-Paré · FRInstitut de Virologie · FRSorbonne Université · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Thanks to the screening method, we estimated among target groups the 2010/2011 field vaccine effectiveness (FVE) against laboratory confirmed influenza cases seen in general practice. We also compared the values of FVE estimations obtained by using three sources of the population vaccination coverage (VC) based on three different methodologies: (1) administrative data from the main social security scheme (Caisse Nationale d'Assurance Maladie des Travailleurs Salariés--CNAMTS) covering about 85% of the French population, (2) a cross-sectional national telephone survey in the general population, and (3) a declarative survey in the population seen in a one-day general practitioner (GP) consultations. The FVE estimates among target groups were stratified by age (< 65 y old with reported chronic illness; ≥65 y old and overall). Using the VC of the CNAMTS, the FVE of the 2010/2011 seasonal trivalent vaccine against laboratory confirmed infection with any influenza virus was 59% (95% Confidence Interval, 17 to 81). It was 85% (17 to 99) and 50% (-16 to 80) for A(H1N1)pdm09 and B influenza infections, respectively. The values of FVE using the influenza VC obtained in a sample of the general population and of the population of GPs' patients were 73% (45 to 87) and 82% (63 to 92), respectively. We estimated a moderate influenza FVE in preventing confirmed influenza viruses in target groups by using the VC of the CNAMTS. We also observed that the screening method generates FVE values dependent on the choice of the source of VC and thus should be used cautiously.

Indexed as

AdolescentAdultAgedAged, 80 and overChildChild, PreschoolData CollectionFemaleFranceHumansInfantInfluenza, HumanInfluenza VaccinesMaleMiddle AgedTreatment OutcomeInfluenza Vaccinesgeneral practitionersinfluenzatarget groupsvaccination coveragevaccine effectiveness

Identifiers

PMID23811610
PMCPMC3981856
OpenAlexW2005806029

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.